Xenon Pharmaceuticals (XENE) announced the appointment of Tucker Kelly as Chief Financial Officer, CFO, and member of the Xenon senior executive team. Kelly most recently served as Executive Vice President, CFO and Treasurer at Deciphera Pharmaceuticals
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XENE:
- Promising Outlook on Xenon Pharmaceuticals: Buy Rating Backed by Innovative Pain Treatment Developments
- Xenon Pharmaceuticals Issues Equity Inducement Grants to New Employees
- Xenon Pharmaceuticals to Host Investor Webinar on Non-Opioid Pain Treatments
- Xenon Pharmaceuticals assumed with an Overweight at Wells Fargo
- Xenon Pharmaceuticals’ Earnings Call Highlights Progress and Promise